Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2015, Article ID 540271, 5 pages
http://dx.doi.org/10.1155/2015/540271
Clinical Study

An Additive Effect of Oral N-Acetyl Cysteine on Eradication of Helicobacter pylori

1Division of Gastroenterology, Department of Internal Medicine, Babol University of Medical Sciences, Babol 47176 41367, Iran
2Division of Gastroenterology, Department of Internal Medicine, Tehran University of Medical Sciences, Tehran, Iran
3Young Researchers Club, Islamic Azad University, Babol Branch, Babol, Iran

Received 24 May 2015; Revised 8 August 2015; Accepted 24 August 2015

Academic Editor: Hin-Chung Wong

Copyright © 2015 Seyed Mohammad-Taghi Hamidian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Passaro, E. J. Chosy, and J. Parsonnet, “Helicobacter pylori: consensus and controversy,” Clinical Infectious Diseases, vol. 35, no. 3, pp. 298–304, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Jahani, R. Shafiee, P. Safavi et al., “Prevalence of parasites in the small intestine of patients with dyspepsia undergoing upper gastrointestinal endoscopy, Tehran in 2005–2007,” Journal of Babol University of Medical Sciences, vol. 10, no. 1, pp. 60–66, 2009. View at Google Scholar
  3. B. D. Gold, R. B. Colletti, M. Abbott et al., “Helicobacter pylori infection in children: recommendations for diagnosis and treatment,” Journal of Pediatric Gastroenterology & Nutrition, vol. 31, no. 5, pp. 490–497, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Y. Kim and S. W. Jung, “Helicobacter pylori eradication therapy in Korea,” The Korean Journal of Gastroenterology, vol. 58, no. 2, pp. 67–73, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Zullo, C. Hassan, L. Ridola, V. De Francesco, and D. Vaira, “Standard triple and sequential therapies for Helicobacter pylori eradication: an update,” European Journal of Internal Medicine, vol. 24, no. 1, pp. 16–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Culley and E. P. Krenzelok, “A clinical and pharmacoeconomic justification for intravenous acetylcysteine: a US perspective,” Toxicological Reviews, vol. 24, no. 2, pp. 131–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. J. Millea, “N-acetylcysteine: multiple clinical applications,” American Family Physician, vol. 80, no. 3, pp. 265–269, 2009. View at Google Scholar · View at Scopus
  8. A. Karbasi, S. Hossein Hosseini, M. Shohrati, M. Amini, and B. Najafian, “Effect of oral N-acetyl cysteine on eradication of Helicobacter pylori in patients with dyspepsia,” Minerva Gastroenterologica e Dietologica, vol. 59, no. 1, pp. 107–112, 2013. View at Google Scholar · View at Scopus
  9. A. K. Gurbuz, A. M. Ozel, R. Ozturk, S. Yildirim, Y. Yazgan, and L. Demirturk, “Effect of N-acetyl cysteine on Helicobacter pylori,” Southern Medical Journal, vol. 98, no. 11, pp. 1095–1097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Makipour and F. K. Friedenberg, “The potential role of N-acetylcysteine for the treatment of Helicobacter pylori,” Journal of Clinical Gastroenterology, vol. 45, no. 10, pp. 841–843, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Q. Huynh, R. T. L. Couper, C. D. Tran, L. Moore, R. Kelso, and R. N. Butler, “N-acetylcysteine, a novel treatment for Helicobacter pylori infection,” Digestive Diseases and Sciences, vol. 49, no. 11-12, pp. 1853–1861, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Bazzoli, M. Zagari, P. Pozzato et al., “Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study,” Alimentary Pharmacology & Therapeutics, vol. 12, no. 5, pp. 439–445, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Zala, R. Flury, J. Wust, C. Meyenberger, R. Ammann, and H. Wirth, “Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine,” Schweizerische Medizinische Wochenschrift, vol. 124, pp. 1391–1397, 1994. View at Google Scholar
  14. G. Cammarota, G. Branca, F. Ardito et al., “Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial,” Clinical Gastroenterology and Hepatology, vol. 8, no. 9, pp. 817.e3–820.e3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Bagchi, G. Bhattacharya, and S. J. Stohs, “Production of reactive oxygen species by gastric cells in association with Helicobacter pylori,” Free Radical Research, vol. 24, no. 6, pp. 439–450, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Katsurahara, Y. Kobayashi, M. Iwasa et al., “Reactive nitrogen species mediate DNA damage in Helicobacter pylori-infected gastric mucosa,” Helicobacter, vol. 14, no. 6, pp. 552–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Ernst, “Review article: the role of inflammation in the pathogenesis of gastric cancer,” Alimentary Pharmacology & Therapeutics, vol. 13, supplement s1, pp. 13–18, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. D. T. Smoot, T. B. Elliott, H. W. Verspaget et al., “Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury,” Carcinogenesis, vol. 21, no. 11, pp. 2091–2095, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kalousová, T. Zima, V. Tesař, S. Dusilová-Sulková, and J. Škrha, “Advanced glycoxidation end products in chronic diseases—clinical chemistry and genetic background,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 579, no. 1-2, pp. 37–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Hayakawa, H. Miyashita, I. Sakamoto et al., “Evidence that reactive oxygen species do not mediate NF-κB activation,” The EMBO Journal, vol. 22, no. 13, pp. 3356–3366, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. P. N. R. Dekhuijzen, “Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 23, no. 4, pp. 629–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. P. V. Sherwood, J. I. D. Wibawa, J. C. Atherton et al., “Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats,” Gut, vol. 51, no. 4, pp. 490–495, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Hogan, M. Ainsworth, and J. Isenberg, “Review article: gastroduodenal bicarbonate secretion,” Alimentary Pharmacology & Therapeutics, vol. 8, no. 5, pp. 475–488, 1994. View at Google Scholar
  24. R.-Q. Wang and D.-C. Fang, “Effects of Helicobacter pylori infection on mucin expression in gastric carcinoma and pericancerous tissues,” Journal of Gastroenterology and Hepatology, vol. 21, no. 2, pp. 425–431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Gotoh, T. Akamatsu, T. Shimizu et al., “Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori,” Helicobacter, vol. 7, no. 3, pp. 183–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. P. M. Goggin, J. M. Marrero, R. T. Spychal, P. A. Jackson, C. M. Corbishley, and T. C. Northfield, “Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication,” Gastroenterology, vol. 103, no. 5, pp. 1486–1490, 1992. View at Google Scholar · View at Scopus